Gene: SLC35G1
Official Full Name: solute carrier family 35 member G1provided by HGNC
Gene Summary: This gene encodes a transmembrane protein which is a member of the drug/metabolite transporter protein superfamily. The encoded protein may play a role in the regulation of calcium levels inside the cell. [provided by RefSeq, Sep 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14010 | SLC35G1 Knockout cell line (HeLa) | Human | SLC35G1 | 1:3~1:6 | Negative | Online Inquiry |
KO14011 | SLC35G1 Knockout cell line (HCT 116) | Human | SLC35G1 | 1:2~1:4 | Negative | Online Inquiry |
KO14012 | SLC35G1 Knockout cell line (HEK293) | Human | SLC35G1 | 1:3~1:6 | Negative | Online Inquiry |
KO14013 | SLC35G1 Knockout cell line (A549) | Human | SLC35G1 | 1:3~1:4 | Negative | Online Inquiry |
SLC35G1 Gene Knockout Cell Lines are specifically engineered cell lines in which the SLC35G1 gene, known for its role in nucleotide sugar transport and glycosylation processes, has been inactivated through targeted gene editing techniques such as CRISPR/Cas9. This product serves as a vital tool for researchers in molecular biology, genetics, and cellular physiology, allowing for the investigation of SLC35G1's physiological functions and its implications in various biological pathways.
The key function of SLC35G1-related cell lines lies in their ability to elucidate the consequences of gene disruption on cellular metabolism, signaling, and glycoprotein synthesis. By creating a controlled environment where the SLC35G1 gene is absent, researchers can study the resulting changes in intracellular transport mechanisms, the alteration in glycan structures, and the subsequent impacts on protein function and cell behavior.
In scientific settings, these knockout cell lines are invaluable for advancing our understanding of diseases associated with glycosylation defects, such as certain immunological disorders and cancers. They facilitate the screening of therapeutic compounds and the development of gene editing strategies, ultimately contributing to more targeted and effective treatments.
The advantages of SLC35G1 Gene Knockout Cell Lines over other alternatives, such as wild-type or non-targeted cell lines, include their precision in modeling specific genetic alterations and their ability to provide clearer insights into the molecular ramifications of SLC35G1 disruption. This specificity can lead to more relevant data in research applications, enhancing the reliability of experimental results.
For researchers and clinicians focused on glycosylation and its diverse effects on health and disease, employing SLC35G1 Gene Knockout Cell Lines represents a significant step forward in experimental design and hypotheses testing. Our company, with its commitment to providing high-quality biological research tools, ensures that these cell lines are rigorously validated and come with comprehensive documentation, making them a trusted asset in your research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.